Veradigm Management

Management criteria checks 2/4

Veradigm's CEO is Tom Langan, appointed in May 2022, has a tenure of 2.5 years. directly owns 0.2% of the company’s shares, worth $3.54M. The average tenure of the management team and the board of directors is 3.8 years and 6.5 years respectively.

Key information

Tom Langan

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure2.5yrs
CEO ownership0.2%
Management average tenure3.8yrs
Board average tenure6.5yrs

Recent management updates

Recent updates

Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price

Feb 28
Veradigm (NASDAQ:MDRX) Is Doing The Right Things To Multiply Its Share Price

Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger

Nov 10
Veradigm (NASDAQ:MDRX) Might Have The Makings Of A Multi-Bagger

Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher

Mar 06
Veradigm's (NASDAQ:MDRX) Returns On Capital Are Heading Higher

Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?

Feb 13
Is It Too Late To Consider Buying Veradigm Inc. (NASDAQ:MDRX)?

Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate

Jan 22
Veradigm Inc. (NASDAQ:MDRX) Shares Could Be 47% Below Their Intrinsic Value Estimate

These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well

Jan 04
These 4 Measures Indicate That Veradigm (NASDAQ:MDRX) Is Using Debt Reasonably Well

Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)

Dec 03
Returns Are Gaining Momentum At Allscripts Healthcare Solutions (NASDAQ:MDRX)

Allscripts Healthcare reaffirms 2022 financial guidance; shares fall 2%

Sep 28

Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?

Sep 17
Should You Think About Buying Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Now?

Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist

Aug 24
Investors Will Want Allscripts Healthcare Solutions' (NASDAQ:MDRX) Growth In ROCE To Persist

We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt

Jul 31
We Think Allscripts Healthcare Solutions (NASDAQ:MDRX) Is Taking Some Risk With Its Debt

Is Now An Opportune Moment To Examine Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?

Jun 15
Is Now An Opportune Moment To Examine Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX)?

We Like These Underlying Return On Capital Trends At Allscripts Healthcare Solutions (NASDAQ:MDRX)

May 03
We Like These Underlying Return On Capital Trends At Allscripts Healthcare Solutions (NASDAQ:MDRX)

CEO

Tom Langan (58 yo)

2.5yrs

Tenure

Mr. Thomas J. Langan, also known as Tom, serves as CEO of Veradigm Inc. since June 7, 2024. He serves as President at Veradigm Inc. (formerly known as Allscripts Healthcare Solutions, Inc.) since May 06, 2...


Leadership Team

NamePositionTenureCompensationOwnership
P. Garrison
Executive Chairman of the Board9.3yrsUS$303.00k0.044%
$ 804.3k
Tejal Vakharia
Senior VP of Marketing & Government Affairs4.4yrsUS$2.08m0.12%
$ 2.2m
Thomas Langan
President & Chief Commercial Officer and Interim CEO2.5yrsno data0.20%
$ 3.5m
Leland Westerfield
Interim CFO and Principal Financial & Accounting Officerless than a yearno datano data
Jenny Gelinas
Vice President of Investor Relations3.8yrsno datano data
Richard Elmore
Senior Vice President of Corporate Development & Strategy5.8yrsno datano data
Lisa Hammond
Senior VP & Chief Human Resources Officer3.5yrsno data0.015%
$ 265.3k
John Sage
Senior Vice President of U.S. Hospitals & Health Systems Sales9.9yrsno datano data
Elliot Bryant
Senior VP & General Manager for Classic Client Solutions Business Unit4.3yrsno datano data
John Mayr
Senior Vice President of Global Client Delivery Organization2.8yrsno datano data
Alan Fowles
President of Allscripts International7.8yrsno datano data
Eric Jacobson
Senior VP & Corporate Secretaryno datano datano data

3.8yrs

Average Tenure

54yo

Average Age

Experienced Management: MDRX's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
P. Garrison
Executive Chairman of the Board9.3yrsUS$303.00k0.044%
$ 804.3k
Jonathan Judge
Independent Director8.5yrsUS$301.00k0.091%
$ 1.6m
Carol Zierhoffer
Lead Independent Director4.3yrsUS$277.50k0.037%
$ 675.1k
David Stevens
Independent Director8.5yrsUS$281.50k0.032%
$ 569.7k
Kim Franks
Member of Advisory Boardno datano datano data
Elizabeth Altman
Independent Director4.4yrsUS$277.50k0.033%
$ 603.5k
Susan Rodriguez
Director1.8yrsno data0.012%
$ 224.5k
Jeanne Armstrong
Member of Advisory Boardno datano datano data
Geoff Caplea
Member of Advisory Boardno datano datano data
Laura Kohlhagen
Member of Advisory Boardno datano datano data
Debbie McKay
Member of Advisory Boardno datano datano data
Ramanujam Venugopalan
Member of Advisory Boardno datano datano data

6.5yrs

Average Tenure

62.5yo

Average Age

Experienced Board: MDRX's board of directors are considered experienced (6.5 years average tenure).